Details of the Drug
General Information of Drug (ID: DMSQ6U6)
Drug Name |
Treprostinil palmitil
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Treprostinil palmitil; treprostinil hexadecyl ester; Hexadecyl treprostinil; INS1009; 1706528-83-7; Treprostinil palmitil [INN]; Treprostinil palmitil [USAN]; 8GJK87S89F; UNII-8GJK87S89F; Treprostinil palmitil [USAN:INN]; INS-1009; WHO 11087; hexadecyl 2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetate; CHEMBL4650232; SCHEMBL22596768; GLXC-26976; AKOS040756993; MS-30736; HY-109163; CS-0116342; Q27270416; ACETIC ACID, 2-(((1R,2R,3AS,9AS)-2,3,3A,4,9,9A-HEXAHYDRO-2-HYDROXY-1-((3S)- 3-HYDROXYOCTYL)-1H-BENZ(F)INDEN-5-YL)OXY)-, HEXADECYL ESTER; HEXADECYL 2-(((1R,2R,3AS,9AS)-2-HYDROXY-1-((S)-3-HYDROXYOCTYL)-2,3,3A,4,9,9A-HEXAHYDRO-1H-CYCLOPENTA(B)NAPHTHALEN-5-YL)OXY)ACETATE
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecule
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL is unavailable | 2D MOL | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||